Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
250
Trial Sponsor
Clinical Trial Start Date
June 24, 2019
0Primary Completion Date
December 3, 2021
0Study Completion Date
December 27, 2021
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Device0
Drug0
Intervention Name
Acetaminophen0
HTX-0110
Ibuprofen0
Luer Lock Applicator0
Interventional Trial Phase
Phase 20
Participating Facility
Official Name
A Phase 2 Open-Label Study of the Pharmacokinetics (PK) and Safety of HTX-011 Administered Postpartum to Women Undergoing a Planned Caesarean Section0
Last Updated
March 14, 2022
0Allocation Type
Non-Randomized0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Study summary
This is a Phase 2, open-label study to evaluate the PK and safety of HTX-011 in women undergoing a planned C-section.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
